Menu Philippe 4

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 1,600 shares on April 14, 2026. The weighted-average reported price was $4.96 per share, for total proceeds of $7,933. This was a sale (not a purchase) and appears to be a routine disposition.

Key Details

• Transaction date: 2026-04-14; filing date: 2026-04-16 (filed within the typical 2-business-day Form 4 window).
• Price info: weighted-average $4.96; individual sale prices ranged from $4.78 to $5.16 (per footnote), with the filer offering to provide a per-price breakdown on request.
• Method: reported as an open-market or private sale (S); footnote states the transaction was made pursuant to a pre-established Rule 10b5-1(c) trading plan.
• Shares owned after transaction: not specified in the information provided in your summary.
• No indication in the filing of tax withholding, option exercise, gift, or other non-sale codes.

Context

• Sales executed under a 10b5-1 plan are pre-planned and commonly used to avoid trading on inside information; they are generally considered routine and do not by themselves indicate the insider’s view of the company’s prospects. Purchases tend to be more informative for bullish signals; this entry documents a modest sale.